InMode Ltd. (NASDAQ:INMD – Get Free Report)’s share price reached a new 52-week low during mid-day trading on Thursday. The company traded as low as $12.61 and last traded at $12.6950, with a volume of 61,684 shares changing hands. The stock had previously closed at $12.88.
Wall Street Analyst Weigh In
Several analysts have recently issued reports on INMD shares. Robert W. Baird lowered their price objective on shares of InMode from $17.00 to $15.00 and set a “neutral” rating for the company in a research note on Thursday, November 12th. Weiss Ratings raised InMode from a “sell (d)” rating to a “sell (d+)” rating in a research report on Tuesday. One research analyst has rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, InMode has an average rating of “Hold” and an average target price of $16.33.
Read Our Latest Analysis on InMode
InMode Stock Performance
The firm has a fifty day moving average of $13.99 and a 200-day moving average of $14.25. The stock has a market capitalization of $732.37 million, a price-to-earnings ratio of 10.56 and a beta of 1.98.
InMode (NASDAQ:INMD – Get Free Report) last announced its earnings results on Wednesday, November 11th. The healthcare company reported $0.37 earnings per share for the quarter, beating the consensus estimate of $0.32 by $0.05. InMode had a return on equity of 11.55% and a net margin of 19.94%. The company had revenue of $92.14 million during the quarter, compared to the consensus estimate of $91.58 million. During the same period last year, the firm earned $0.38 earnings per share. The company’s revenue was down 1.1% on a year-over-year basis.
Institutional Trading of InMode
Several institutional investors have recently added to or reduced their stakes in INMD. IFP Advisors Inc bought a new position in shares of InMode in the 2nd quarter worth about $31,000. Parallel Advisors LLC grew its position in shares of InMode by 43.3% during the 3rd quarter. Parallel Advisors LLC now owns 4,934 shares of the healthcare company’s stock valued at $70,000 after buying an additional 1,490 shares during the last quarter. Aquatic Capital Management LLC bought a new stake in shares of InMode during the 3rd quarter valued at about $82,000. Hsbc Holdings PLC acquired a new stake in InMode during the first quarter worth about $163,000. Finally, Signaturefd LLC raised its stake in InMode by 50.0% during the third quarter. Signaturefd LLC now owns 12,014 shares of the healthcare company’s stock worth $170,000 after acquiring an additional 4,006 shares during the period. Institutional investors own 68.04% of the company’s stock.
InMode Company Profile
InMode Ltd. is an Israel-based medical technology company that develops energy-based systems for minimally invasive aesthetic and medical procedures. Its technologies use radiofrequency energy to support treatments such as body contouring, skin tightening and facial rejuvenation, as well as certain women’s health applications. The company’s product portfolio includes platforms and handpieces such as BodyTite and FaceTite for body and facial contouring, and Morpheus8 for fractional radiofrequency skin treatments.
Featured Stories
- Five stocks we like better than InMode
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
- 3 Niche ETFs Are Beating the S&P 500, and Their Strategies Are Anything but Typical
Receive News & Ratings for InMode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InMode and related companies with MarketBeat.com's FREE daily email newsletter.
